Bio-Techne Corporation (NasdaqGS:TECH) is looking for M&A. James Hippel, Chief Financial Officer said, "Our balance sheet finished third quarter in a strong position with $157.2 million in cash and short-term available for sale investments. And our total leverage ratio remains below [ 1:10 ]. And going forward, M&A remains a top priority for capital allocation".